Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Cash & Current Investments (2016 - 2026)

Corcept Therapeutics' Cash & Current Investments history spans 17 years, with the latest figure at $338.2 million for Q1 2026.

  • On a quarterly basis, Cash & Current Investments rose 4.78% to $338.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $338.2 million, a 4.78% increase, with the full-year FY2025 number at $372.2 million, down 2.92% from a year prior.
  • Cash & Current Investments hit $338.2 million in Q1 2026 for Corcept Therapeutics, down from $372.2 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for CORT hit a ceiling of $473.2 million in Q2 2024 and a floor of $322.8 million in Q1 2025.
  • Historically, Cash & Current Investments has averaged $384.7 million across 5 years, with a median of $372.2 million in 2025.
  • Biggest five-year swings in Cash & Current Investments: skyrocketed 93.11% in 2022 and later decreased 27.67% in 2025.
  • Tracing CORT's Cash & Current Investments over 5 years: stood at $431.7 million in 2022, then fell by 14.7% to $368.2 million in 2023, then rose by 4.1% to $383.3 million in 2024, then dropped by 2.92% to $372.2 million in 2025, then dropped by 9.13% to $338.2 million in 2026.
  • Business Quant data shows Cash & Current Investments for CORT at $338.2 million in Q1 2026, $372.2 million in Q4 2025, and $421.7 million in Q3 2025.